TipRanks
Go Ultimate55% OFF

Monte Rosa Therapeutics (GLUE) Balance Sheet

Monte Rosa Therapeutics Balance Sheet

Monte Rosa Therapeutics's total assets for Q2 2026 were $696.08M, a decrease of 5.48% from the previous quarter. GLUE total liabilities were $211.03M for the fiscal quarter, a 1.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 448.66M$ 438.73M$ 303.75M$ 342.39M$ 366.33M
$ 215.60M$ 215.80M$ 124.50M$ 70.98M$ 18.81M
$ 233.06M$ 222.94M$ 179.25M$ 271.41M$ 347.51M

Currency in USD

Monte Rosa Therapeutics Debt to Assets

0200M400M600M0 %80 %160 %240 %LiabilitiesDebt to Assets2019202020212022202320242025AssetsLiabilitiesDebt to Assets